AREA
Cognitive Neuroscience
SITE
Alzheimer’s & dementia (Amsterdam, Netherlands)
TYPE
Articles
YEAR
Formal publication: January 2022
Abstract:Introduction: Automated speech analysis has emerged as a scalable, cost-effective tool to identify persons with Alzheimer’s disease dementia (ADD). Yet, most research is undermined by low interpretability and specificity.
Methods: Combining statistical and machine learning analyses of natural speech data, we aimed to discriminate ADD patients from healthy controls (HCs) based on automated measures of domains typically affected in ADD: semantic granularity (coarseness of concepts) and ongoing semantic variability (conceptual closeness of successive words). To test for specificity, we replicated the analyses on Parkinson’s disease (PD) patients.
Results: Relative to controls, ADD (but not PD) patients exhibited significant differences in both measures. Also, these features robustly discriminated between ADD patients and HC, while yielding near-chance classification between PD patients and HCs.
Discussion: Automated discourse-level semantic analyses can reveal objective, interpretable, and specific markers of ADD, bridging well-established neuropsychological targets with digital assessment tools.
Related Publications
-
The Brain Health Diplomat’s Toolkit: supporting brain health diplomacy leaders in Latin America and the Caribbean
-
Navigating the multiple dimensions of the creativity-mental disorder link: a Convergence Mental Health perspective
-
Global South research is critical for understanding brain health, ageing and dementia
-
The Human Affectome